John Dickinson
No más puestos en curso
Perfil
John Dickinson formerly worked at Spie Batignolles SAS, as Chief Financial Officer & Vice President, Clintec International, Inc. (Illinois), as Principal, Galderma International SAS, as Chief Financial Officer & Vice President, and Gene Signal International SA, as Chief Corporate Development Officer.
Antiguos cargos conocidos de John Dickinson.
| Empresas | Cargo | Fin |
|---|---|---|
Spie Batignolles SAS
 Spie Batignolles SAS Engineering & ConstructionIndustrial Services Spie Batignolles SA provides construction services. It specializes in engineering, civil works, sanitation, maintenance, and remodeling solutions for commercial buildings and industrial projects. The company was founded in 1968 and is headquartered in Neuilly-sur-Seine, France. | Director Financiero/CFO | - |
Galderma International SAS
 Galderma International SAS Pharmaceuticals: MajorHealth Technology Galderma SA develops and markets therapeutic and aesthetic solutions for dermatology. It provides medical dermatological solutions for acne, rosacea, psoriasis and other steroid-responsive dermatoses, onychomycosis, pigmentary disorders, skin cancer and medical aesthetic and corrective solutions for skin senescence. The company was founded in 1981 and is headquartered in Paris, France. | Director Financiero/CFO | - |
Clintec International, Inc. (Illinois)
 Clintec International, Inc. (Illinois) Pharmaceuticals: MajorHealth Technology Part of Baxter International, Inc., Clintec International, Inc. is a pharmaceutical company based in Deerfield, IL. The company specializes in the development and distribution of pharmaceutical products. | Corporate Officer/Principal | - |
Gene Signal International SA
 Gene Signal International SA Pharmaceuticals: MajorHealth Technology Gene Signal International SA engages in the development of drugs to manage angiogenesis based conditions. It is a research based biotechnology company specialized in the discovery, development, and commercialization of a new class of oligonucleotides, proteins and monoclonal antibodies to treat a range of conditions where angiogenesis plays a determinant role. The company was founded by Eric Viaud, Salman Al-Mahmood, and Eric Thorin in 2000 and is headquartered in Lausanne, Switzerland. | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Spie Batignolles SAS
Spie Batignolles SAS Engineering & ConstructionIndustrial Services Spie Batignolles SA provides construction services. It specializes in engineering, civil works, sanitation, maintenance, and remodeling solutions for commercial buildings and industrial projects. The company was founded in 1968 and is headquartered in Neuilly-sur-Seine, France. | Industrial Services |
Clintec International, Inc. (Illinois)
Clintec International, Inc. (Illinois) Pharmaceuticals: MajorHealth Technology Part of Baxter International, Inc., Clintec International, Inc. is a pharmaceutical company based in Deerfield, IL. The company specializes in the development and distribution of pharmaceutical products. | Health Technology |
Galderma International SAS
Galderma International SAS Pharmaceuticals: MajorHealth Technology Galderma SA develops and markets therapeutic and aesthetic solutions for dermatology. It provides medical dermatological solutions for acne, rosacea, psoriasis and other steroid-responsive dermatoses, onychomycosis, pigmentary disorders, skin cancer and medical aesthetic and corrective solutions for skin senescence. The company was founded in 1981 and is headquartered in Paris, France. | Health Technology |
Gene Signal International SA
Gene Signal International SA Pharmaceuticals: MajorHealth Technology Gene Signal International SA engages in the development of drugs to manage angiogenesis based conditions. It is a research based biotechnology company specialized in the discovery, development, and commercialization of a new class of oligonucleotides, proteins and monoclonal antibodies to treat a range of conditions where angiogenesis plays a determinant role. The company was founded by Eric Viaud, Salman Al-Mahmood, and Eric Thorin in 2000 and is headquartered in Lausanne, Switzerland. | Health Technology |
- Bolsa de valores
- Insiders
- John Dickinson
